Latest News

Biogen's Salanersen Shows Promising Phase 1 Data in Spinal Muscular Atrophy
Biogen's Salanersen Shows Promising Phase 1 Data in Spinal Muscular Atrophy

July 1st 2025

New phase 1 data revealed salanersen's promise to slow neurodegeneration in spinal muscular atrophy, potentially paving the way for future phase 3 trials.

Becker Agent Sevasemten Shows Long-Term Treatment Effects in Latest Extension Data
Becker Agent Sevasemten Shows Long-Term Treatment Effects in Latest Extension Data

July 1st 2025

Studying an Oral Nighttime Therapy in Mild to Severe Obstructive Sleep Apnea: The LunAIRo Trial
Studying an Oral Nighttime Therapy in Mild to Severe Obstructive Sleep Apnea: The LunAIRo Trial

June 30th 2025

Most Impactful Neurology Trial Readouts From Early 2025
Most Impactful Neurology Trial Readouts From Early 2025

June 30th 2025

This Week on NeurologyLive® — June 30, 2025
This Week on NeurologyLive® — June 30, 2025

June 30th 2025

Coverage of SLEEP 2025

Get direct access to interviews with experts, straight from the conference floor in Seattle, as well as the latest data and clinical news updates.

SLEEP 2025

Conference Coverage

View All
 Esther Labib-Kiyarash, MSHA, CPHQ
Sharing Treatment Strategies for Patients With Parkinson Disease Beyond Medication: Esther Labib-Kiyarash, MSHA, CPHQ

July 1st 2025

Justin Martello, MD
Increased Awareness for Essential Tremor Treatment, MR-guided Focused Ultrasound: Justin Martello, MD

July 1st 2025

William Ondo, MD
Understanding the Phenomenology and Impact of Psychosis in Parkinson Disease: William Ondo, MD

June 30th 2025

Jennifer Corcoran, MD
Incorporating Palliative Care Principles into Movement Disorder Management: Jennifer Corcoran, MD

June 30th 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.